Manufacturers Wait Anxiously for CMS Decision on Automatic Medicare Coverage of MCIT Breakthrough Devices

Manufacturers Wait Anxiously for CMS Decision on Automatic Medicare Coverage of MCIT Breakthrough Devices

by Glenn S. Demby | Jul 1, 2021 | Articles, CMS-lir, Essential, FDA-lir, Laboratory Industry Report

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

CMS Proposes to Ease but Not End Hospital Price Transparency

CMS Proposes to Ease but Not End Hospital Price Transparency

by Glenn S. Demby | Jun 28, 2021 | Articles, CMS-nir, Essential, Fee Schedules-nir, National Lab Reporter, Reimbursement-nir

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

ACLA Keeps the Pressure on CMS by Appealing Dismissal of PAMA Lawsuit

ACLA Keeps the Pressure on CMS by Appealing Dismissal of PAMA Lawsuit

by Glenn S. Demby | Jun 28, 2021 | Articles, CMS-lir, Essential, Laboratory Industry Report

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

OIG Calls on CMS to Crack Down on Improper Payment of Definitive Drug and LDL Cholesterol Tests

by Glenn S. Demby | Jun 28, 2021 | Articles, CMS-nir, Essential, National Lab Reporter, Reimbursement-nir

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

Manufacturers Wait Anxiously for CMS Decision on Automatic Medicare Coverage of MCIT Breakthrough Devices

Manufacturers Wait Anxiously for CMS Decision on Automatic Medicare Coverage of MCIT Breakthrough Devices

by Glenn S. Demby | Jun 8, 2021 | Articles, CMS-lir, Essential, FDA-lir, Laboratory Industry Report, LDTs-lir, Must read

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

« Older Entries

Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Email*

Country*